Talphera, Inc. (TLPH)
0.73
-0.01
(-1.22%)
USD |
NASDAQ |
Nov 20, 10:47
Talphera Cash from Investing (Quarterly) : 12.92M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 12.92M |
| June 30, 2026 | 1.104M |
| March 31, 2026 | -2.714M |
| December 31, 2025 | 3.47M |
| September 30, 2025 | -17.82M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.60M |
| June 30, 2024 | 5.911M |
| March 31, 2024 | -2.73M |
| December 31, 2023 | -3.651M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 2.723M |
| March 31, 2023 | 0.40M |
| December 31, 2022 | 2.66M |
| September 30, 2022 | 4.442M |
| June 30, 2022 | 9.172M |
| March 31, 2022 | 20.18M |
| December 31, 2021 | -4.439M |
| September 30, 2021 | -6.652M |
| June 30, 2021 | 2.393M |
| March 31, 2021 | -17.42M |
| December 31, 2020 | 5.775M |
| September 30, 2020 | -1.214M |
| Date | Value |
|---|---|
| June 30, 2020 | 6.928M |
| March 31, 2020 | 22.65M |
| December 31, 2019 | 6.889M |
| September 30, 2019 | -33.21M |
| June 30, 2019 | -10.62M |
| March 31, 2019 | 0.371M |
| December 31, 2018 | -11.96M |
| September 30, 2018 | 10.71M |
| June 30, 2018 | -9.428M |
| March 31, 2018 | -0.203M |
| December 31, 2017 | -7.475M |
| September 30, 2017 | -0.534M |
| June 30, 2017 | -1.425M |
| March 31, 2017 | -0.536M |
| December 31, 2016 | -1.837M |
| September 30, 2016 | -0.578M |
| June 30, 2016 | 0.609M |
| March 31, 2016 | 3.615M |
| December 31, 2015 | 3.379M |
| September 30, 2015 | 5.801M |
| June 30, 2015 | -0.463M |
| March 31, 2015 | -0.514M |
| December 31, 2014 | -0.765M |
| September 30, 2014 | -3.552M |
| June 30, 2014 | -0.217M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Relmada Therapeutics, Inc. | 6.954M |
| Journey Medical Corp. | 0.00 |
| ANI Pharmaceuticals, Inc. | -13.50M |
| Corcept Therapeutics, Inc. | -131.99M |
| Veru, Inc. | 1.802M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.034M |
| Cash from Financing (Quarterly) | 0.032M |
| Free Cash Flow | -12.79M |
| Free Cash Flow Per Share (Quarterly) | -0.0402 |
| Free Cash Flow to Equity (Quarterly) | -3.034M |
| Free Cash Flow to Firm (Quarterly) | -3.034M |
| Free Cash Flow Yield | -33.74% |